Thèse Amandine Martin - EPHE

18. Kelly, P.N. et al. Tumor growth need not be driven by rare cancer stem cells. Science
(New York, N.Y.) 317, 337(2007).
19. El Hage, F. et al. [Immune response and cancer]. Bulletin du cancer 95, 57-67(2008).
20. UICC, Union for International Cancer Control.
21. Tjandra, J.J. & Chan, M.K.Y. Follow-up after curative resection of colorectal cancer: a
meta-analysis. Diseases of the colon and rectum 50, 1783-99(2007).
22. Kahnamoui, K. et al. Laparoscopic surgery for colon cancer: a systematic review.
Canadian journal of surgery. Journal canadien de chirurgie 50, 48-57(2007).
23. Bemelman, W.A. Minimally invasive surgery for early lower GI cancer. Best practice
& research. Clinical gastroenterology 19, 993-1005(2005).
24. Gillams, A.R. The use of radiofrequency in cancer. British Journal of Cancer 1825 -
1829(2005).doi:10.1038/sj.bjc.6602582
25. SKIPPER, H.E. & THOMSON, J.R. Effects of a series of tumor-inhibiting agents and
related compounds on L1210 leukemia and drug-resistant lines thereof. Cancer
research Suppl. 3, 44-6(1955).
26. Grivicich, I., Peters, G.J. & Schwartsmann, G. Irinotecan and oxaliplatin : an overview
of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
Brazilian Journal Of Medical And Biological Research (2001).
27. Shields, A.F. et al. Treatment of Advanced Colorectal Carcinoma with Oxaliplatin and
Capecitabine. Cancer 531-537(2003).doi:10.1002/cncr.11925
28. Tebbutt, N.C. et al. Systemic treatment of colorectal cancer. European Journal of
Cancer 38, 1000-1015(2002).
29. Coutinho, A.K. & Rocha Lima, C.M. Metastatic colorectal cancer: systemic treatment
in the new millennium. Cancer control : journal of the Moffitt Cancer Center 10, 224-
38
30. Bleiberg, H. & Bruxelles, L.D. Review CPT-11 in Gastrointestinal Cancer. Science 35,
(1999).
31. Extra, J.M. et al. Pharmacokinetics and safety profile of oxaliplatin. Seminars in
oncology 25, 13-22(1998).
32. Wiseman, L.R. et al. Oxaliplatin: a review of its use in the management of metastatic
colorectal cancer. Drugs & aging 14, 459-75(1999).
33. Gramont, A. de et al. Leucovorin and fluorouracil with or without oxaliplatin as firstline
treatment in advanced colorectal cancer. Journal of clinical oncology : official
journal of the American Society of Clinical Oncology 18, 2938-47(2000).
37